Quarterly report [Sections 13 or 15(d)]

Warrants

v3.26.1
Warrants
 3 Months Ended
Mar. 31, 2026
Warrants [Abstract]  
WARRANTS

NOTE 6 – WARRANTS

 

As of March 31, 2026, the fair value of the Public Warrants was approximately $0.226 per Public Warrant based on the closing price of the warrants on The Nasdaq Capital Market. As of March 31, 2026, the fair value of the Representative Warrants was approximately $0.235 per Representative Warrant, which was based on the relative fair value to the Public Warrants.

 

Warrants exercisable at March 31, 2026, were as follows:

 

Exercise Price     Number of warrants     Weighted-average
remaining contractual
term (years)		     Weighted average
exercise price		  
$ 0.72       10,000       9.57       -  
$ 0.94       4,000,000       4.67       -  
$ 1.40       5,536,428       2.85       -  
$ 1.75       250,000       4.10       -  
$ 3.85       2,439,026       1.76       -  
$ 5.13       85,366       3.51       -  
$ 8.13       1,500       7.92       -  
$ 20.00       433,999       0.65       -  
$ 37.60       100,001       1.38       -  
$ 120.00       13,800       0.46       -  
$ 125.00       220,000       0.46       -  

Warrants outstanding as of March 31, 2026

     13,090,120       3.11     $ 4.84  
                             

Warrants exercisable as of March 31, 2026

       13,080,120       3.10     $ 4.85  

 

No warrants expired/cancelled during the three months ended March 31, 2026.

 

For the three months ended March 31, 2026 and 2025, total stock-based compensation expense related to the Company’s warrants was approximately $817 and $1,573, respectively, and is recognized within general and administrative expense on the condensed consolidated statements of operations and comprehensive loss.

 

During the three months ended March 31, 2026 and 2025, the Company issued no warrants.